ClinVar Miner

Submissions for variant NM_002693.3(POLG):c.126GCA[12] (p.Gln55dup)

dbSNP: rs41550117
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 16
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Genetic Services Laboratory, University of Chicago RCV000153756 SCV000248554 benign not specified 2013-10-30 criteria provided, single submitter clinical testing
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia RCV000153756 SCV000257925 likely benign not specified 2015-07-10 criteria provided, single submitter clinical testing
Genomic Research Center, Shahid Beheshti University of Medical Sciences RCV000714693 SCV000845415 benign POLG-Related Spectrum Disorders 2018-08-07 criteria provided, single submitter clinical testing
Ambry Genetics RCV002312681 SCV000846208 benign Inborn genetic diseases 2016-01-08 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Wong Mito Lab, Molecular and Human Genetics, Baylor College of Medicine RCV000758545 SCV000887271 benign Progressive sclerosing poliodystrophy 2018-10-01 criteria provided, single submitter clinical testing The NM_002693.2:c.156_158dup (NP_002684.1:p.Gln53_Gln54insGln) [GRCH38: NC_000015.10:g.89333627_89333629dup] variant in POLG gene is interpretated to be a Benign based on ACMG guidelines (PMID: 25741868). This variant meets the following evidence codes reported in the ACMG-guideline. BS1:The minor allele frequency of this allele is high for Mitochondrial DNA depletion syndrome 4A (Alpers type). BS2:Observation of the variant in controls is inconsistent with penetrance of Mitochondrial DNA depletion syndrome 4A (Alpers type). BP4:Computational evidence/predictors indicate no impact on the POLG structure, function, or protein-protein interaction. Based on the evidence criteria codes applied, the variant is suggested to be Benign.
Labcorp Genetics (formerly Invitae), Labcorp RCV000758545 SCV001717997 benign Progressive sclerosing poliodystrophy 2024-02-01 criteria provided, single submitter clinical testing
GeneDx RCV000676330 SCV001832966 benign not provided 2020-06-03 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 23066759, 29190809)
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000676330 SCV002058045 benign not provided 2023-11-22 criteria provided, single submitter clinical testing
Genome Diagnostics Laboratory, The Hospital for Sick Children RCV001847785 SCV002105551 benign Hereditary spastic paraplegia 2021-12-16 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV002492575 SCV002795443 likely benign Progressive sclerosing poliodystrophy; Mitochondrial DNA depletion syndrome 1; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1; Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis; Mitochondrial DNA depletion syndrome 4b 2021-08-23 criteria provided, single submitter clinical testing
Molecular Genetics, Royal Melbourne Hospital RCV003993835 SCV004812617 benign Recessive mitochondrial ataxia syndrome 2023-06-06 criteria provided, single submitter clinical testing Allele frequency in gnomAD v3.1 is >5% in the African/African American population dataset.
Eurofins Ntd Llc (ga) RCV000153756 SCV000203330 benign not specified 2014-02-19 no assertion criteria provided clinical testing
Mayo Clinic Laboratories, Mayo Clinic RCV000676330 SCV000802100 benign not provided 2016-02-22 no assertion criteria provided clinical testing
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) RCV000676330 SCV001799438 likely benign not provided no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, Amsterdam University Medical Center RCV000153756 SCV001806793 benign not specified no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, University Medical Center Utrecht RCV000153756 SCV001930110 benign not specified no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.